J. E. Everhart and C. E. Ruhl, Burden of digestive diseases in the United States Part III: Liver

Z. Jia, R. Paz-fumagalli, G. Frey, D. M. Sella, J. M. Mckinney et al., , p.391

, Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic 392 cholangiocarcinoma: preliminary results, J Cancer Res Clin Oncol, vol.143, issue.3, pp.481-393, 2017.

P. Reimer, M. K. Virarkar, M. Binnenhei, M. Justinger, M. R. Schön et al., Prognostic 395 Factors in Overall Survival of Patients with Unresectable Intrahepatic 396

, Cholangiocarcinoma Treated by Means of Yttrium-90 Radioembolization: Results in 397 Therapy-Naïve Patients, vol.41, 2018.

N. C. Swinburne, D. M. Biederman, and C. Besa, Radioembolization for Unresectable 400

, Intrahepatic Cholangiocarcinoma: Review of Safety, Response Evaluation Criteria in 401

, Solid Tumors 1.1 Imaging Response and Survival, Cancer Biother Radiopharm, vol.402, issue.5, pp.161-168, 2017.

T. M. Shaker, C. Chung, and M. K. Varma, Is there a role for Ytrrium-90 in the treatment of 404 unresectable and metastatic intrahepatic cholangiocarcinoma?, Am J Surg, vol.215, issue.3, pp.467-470, 2018.

A. Gangi, J. Shah, and N. Hatfield, , p.407

, Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single 408

, Institution Retrospective Study, J Vasc Interv Radiol JVIR, vol.29, issue.8, 2018.

H. Bourien, X. Palard, and Y. Rolland, Yttrium-90 glass microspheres radioembolization 411 (RE) for biliary tract cancer: a large single-center experience, Eur J Nucl Med Mol, p.412

, Imaging, vol.46, issue.3, pp.669-676, 2019.

R. Salem, R. J. Lewandowski, and V. L. Gates, Research reporting standards for 414 radioembolization of hepatic malignancies, J Vasc Interv Radiol JVIR, vol.22, issue.3, pp.265-415, 2011.

E. Garin, L. Lenoir, and J. Edeline, Boosted selective internal radiation therapy with 417

, 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new 418 personalized promising concept, Eur J Nucl Med Mol Imaging, vol.40, issue.7, pp.1057-1068, 2013.

D. P. Al-adra, R. S. Gill, S. J. Axford, X. Shi, N. Kneteman et al., Treatment of 430 unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a 431 systematic review and pooled analysis, Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc, vol.432

, Surg Oncol, vol.41, issue.1, pp.120-127, 2015.

A. Cucchetti, A. Cappelli, and C. Mosconi, Improving patient selection for selective 434 internal radiation therapy of intra-hepatic cholangiocarcinoma: A meta-regression study

R. Shridhar, J. M. Frakes, and B. Yue, Phase II study of first-line radioembolization with 437 yttrium-90 glass microspheres for intrahepatic cholangiocarcinoma, Liver Int Off J Int Assoc Study Liver, vol.37, issue.7, pp.482-482, 2017.

J. Bridgewater, P. R. Galle, and S. A. Khan, Guidelines for the diagnosis and management 440 of intrahepatic cholangiocarcinoma, J Hepatol, vol.60, issue.6, 2014.

J. W. Valle, I. Borbath, S. A. Khan, F. Huguet, T. Gruenberger et al., Biliary cancer: 443 ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, p.444

, Off J Eur Soc Med Oncol, vol.27, issue.5, pp.28-37, 2016.

R. Kloeckner, C. Ruckes, and K. Kronfeld, Selective internal radiotherapy (SIRT) versus 446 transarterial chemoembolization (TACE) for the treatment of intrahepatic 447 cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial

, Trials, vol.15, p.311, 2014.

F. Pardo, B. Sangro, and R. Lee, The Post-SIR-Spheres Surgery Study, vol.4

, Retrospective Analysis of Safety Following Hepatic Resection or Transplantation, p.451

, Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90

R. Microspheres, Ann Surg Oncol, vol.24, issue.9, pp.2465-2473, 2017.

M. Rayar, L. Sulpice, and J. Edeline, Intra-arterial yttrium-90 radioembolization 455 combined with systemic chemotherapy is a promising method for downstaging 456 unresectable huge intrahepatic cholangiocarcinoma to surgical treatment, Ann Surg, p.457

, Oncol, vol.22, issue.9, pp.3102-3108, 2015.

L. Roy, B. Gelli, M. Pittau, and G. , Neoadjuvant chemotherapy for initially unresectable 459 intrahepatic cholangiocarcinoma, Br J Surg, vol.105, issue.7, pp.839-847, 2018.

J. Edeline, M. Benabdelghani, and A. Bertaut, Intra-arterial Therapy for Advanced Intrahepatic 472 Cholangiocarcinoma: A Multi-institutional Analysis, Ann Surg Oncol, vol.473, issue.12, pp.3779-3786, 2013.

T. S. Hong, J. Y. Wo, and B. Y. Yeap, Institutional Phase II Study of High-Dose, vol.475

, Hypofractionated Proton Beam Therapy in Patients With Localized, p.476

H. Carcinoma and I. Cholangiocarcinoma, J Clin Oncol Off J Am, vol.477

, Soc Clin Oncol, vol.34, issue.5, pp.460-468, 2016.

A. Lamarca, Survival Data for Advanced Intrahepatic Cholangiocarcinoma from the 479 ABC-01, -02 And -03 Clinical Studies, ILCA Meet, p.14, 2018.

E. Garin, Y. Rolland, and J. Edeline, Personalized dosimetry with intensification using 481

, 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in 482 hepatocellular carcinoma patients with portal vein thrombosis, J Nucl Med Off Publ Soc, vol.483

, Nucl Med, vol.56, issue.3, pp.339-346, 2015.

E. Garin, Y. Rolland, and M. Pracht, High impact of macroaggregated albumin-based 485 tumour dose on response and overall survival in hepatocellular carcinoma patients 486 treated with (90) Y-loaded glass microsphere radioembolization, Liver Int Off J Int, vol.487

, Assoc Study Liver, vol.37, issue.1, pp.101-110, 2017.